会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 84. 发明授权
    • MICROCRYSTALLINE MATRIX FOR ADMINISTRATION OF BENEFICIAL AGENT
    • 用于管理受益人的微结构矩阵
    • EP0345317B1
    • 1993-08-25
    • EP88910379.2
    • 1988-11-08
    • BAXTER INTERNATIONAL INC. (a Delaware corporation)
    • WEINLESS, Naomi, L.POKROPINSKI, Sharon
    • A61M31/00
    • A61J1/10A61K9/2013A61K9/2018A61M1/02A61M1/1668A61M1/1686A61M1/28A61M5/1409
    • Medical solution is passed in a conduit (10) across a solid, microcrystalline mass (18) of beneficial agent to cause the beneficial agent (18) to dissolve in the medical solution. The beneficial agent (18) comprises a mass of citrate or mannitol in a substantially anhydrous form, the mass (18) being shaped and proportioned so that a controlled amount of the beneficial agent (18) dissolves into passing medical solution in a manner that is substantially predetermined. For example, the beneficial agent (18) can dissolve in substantially uniform manner, whereby no substantial portion of the medical solution, such as blood or another parenteral solution, is exposed at a relatively constant flow to a significantly higher concentration of the beneficial agent than other flowing portions of the medical solution. The citrate or mannitol mass of the beneficial agent (18) may include at least one added effective agent for dissolving in the medical solution as the citrate or mannitol dissolve therein.
    • 医疗溶液通过导管(10)穿过有益剂的固体微晶块(18),以使有益剂(18)溶解在医用溶液中。 有益剂(18)包含基本上无水形式的一批柠檬酸盐或甘露糖醇,所述物质(18)的形状和比例成正比,使受控量的有益剂(18)以下列方式溶解于经过的药物溶液: 基本上预定。 例如,有益剂(18)可以以基本上均匀的方式溶解,由此没有大量部分的药物溶液,例如血液或其他胃肠外溶液以相对恒定的流量暴露于有益剂的显着更高的浓度, 医疗解决方案的其他流动部分。 有益剂(18)的柠檬酸盐或甘露糖醇物质可以包含至少一种添加的有效剂,其溶解在柠檬酸盐或甘露醇中溶于其中。
    • 88. 发明授权
    • PURGING SYSTEM FOR A BLOOD TUBING NETWORK
    • 血液管网络采血系统
    • EP0305364B1
    • 1993-02-24
    • EP87901905.7
    • 1987-02-25
    • BAXTER INTERNATIONAL INC. (a Delaware corporation)
    • WILLIAMSON,warrenPRINCE, Paul, R.
    • A61M1/00A61M37/00
    • A61M1/3643A61M1/3644A61M1/3647A61M1/3672A61M5/385A61M39/14A61M2205/7536
    • Method and apparatus for purging air from a tubing network finds utility as a component part of a blood constituent processing system (10). Collection and returned needles (12, 14) of a disposable tubing network are initially contained within a common antiseptic enclosure (16). A purge fluid (e.g., saline solution) may then be introduced into the interior chamber of the enclosure (16) via one of the needles (12, 14) and withdrawn from the interior chamber of the enclosure (16) via the other of the needles (12, 14). Air entrained in the tubing network may thus be trapped within the common enclosure (16) itself and/or vented therefrom via a one-way valve and hydrophobic microbe filter (72) and/or the entrained air pockets may be encouraged to flow to a separate suitable air trap location (50) of the tubing network whereby the network is purged of air.
    • 从管网净化空气的方法和装置可用作血液成分处理系统(10)的组成部分。 一次性管网的收集和返回的针(12,14)最初被包含在常见的防腐外壳(16)内。 然后可以经由一个针(12,14)将清洗流体(例如,盐水溶液)引入到外壳(16)的内部腔室中,并通过另一个从外壳(16)的内部腔室 针(12,14)。 因此,管道网络中夹带的空气可以通过单向阀和疏水性微生物过滤器(72)本身和/或从其中排出而在公共外壳(16)内被捕获和/或可以鼓励夹带的气囊流到 单独的管道网络的合适的空气阱位置(50),从而净化空气。